Immuneering CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
Immuneering Corporation has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.
NASDAQ
Immuneering Corporation has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.
NASDAQ
Immuneering Corporation will hold its annual meeting of stockholders virtually on June 13, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Immuneering Corporation has filed definitive additional materials related to its proxy statement with the SEC.
NASDAQ
Immuneering Corporation will hold its annual meeting of stockholders virtually on June 12, 2024, to vote on the election of directors and ratification of the independent registered public accounting firm.